Gossamer Bio, Inc. Common Stock

GOSSNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
10.70 USD
↘ 0.03 (0.28%)AT CLOSE (11:59 AM EDT)
10.86
↗ 0.16 (1.45%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
10.86
↗ 0.16 (1.45%)
🔴Market: CLOSED

Gossamer Bio, Inc. Common Stock (GOSS) is currently trading at $10.85. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (133.2%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, GOSS appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Sep 14, 2026.

Open?$10.95
High?$11.08
Low?$10.07
Prev. Close?$10.73
Volume?325.9K
Avg. Volume?18.3M
VWAP?$10.60
Rel. Volume?0.02x
Bid / Ask
Bid?$8.99 × 100
Ask?$12.48 × 100
Spread?$3.49
Midpoint?$10.74
Valuation & Ratios
Market Cap?65.6M
Shares Out?N/A
Float?453.6M
Float %?92.8%
P/E Ratio?N/A
P/B Ratio?-0.70
EPS?-$20.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Themes
Biotech - Drug Development›Rare Disease TherapeuticsBiotech - Drug Development›Immunology & Autoimmune
Employees
162
Market Cap
65.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.gossamerbio.com
Listed
2019-02-08
Address
3115 MERRYFIELD ROW
SAN DIEGO, CA 92121
Phone: (858) 684-1300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
83
Short Sent.?
38
Piotroski F-Score?4/9Mixed
Altman Z-Score?-33.97Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?18.22%High
Short Interest?82.6M
Days to Cover?2.8
Free Float453.6M
Avg Daily Volume29.6M
Settlement Date2026-08-31
Financial Health
Current Ratio?0.53Weak
Quick Ratio?0.53Weak
Cash Ratio?0.30Low
Debt/Equity?-0.38Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-0.70CHEAP▾
P/S?
Peers
100
S&P
83
1.23CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
Peers
100
S&P
90
1.14CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
133.2%STRONG▾
ROA?
S&P
3
-162.9%WEAK▾
Cash Flow & Enterprise
FCF?$-162626000
Enterprise Value?$60.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist